ArticleJournal of asthma and allergy2018

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Moshe Ashkenazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.